🇺🇸 FDA
Patent

US 7067254

Diagnosis and treatment of inflammation and hyperactive immune conditions

granted A61KA61K31/185A61K31/655

Quick answer

US patent 7067254 (Diagnosis and treatment of inflammation and hyperactive immune conditions) held by The Board of Regents of the University of Texas System expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/185, A61K31/655, A61K38/46, A61P